|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2000-2-2
|
|
pubmed:abstractText |
To analyze factors that predict the occurrence of chemotherapy-induced myelosuppression and, in particular, the role of the tumor necrosis factor (TNF) ligand-receptor system in lymphoma patients at the beginning of their treatment.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
325-31
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10637246-Adult,
pubmed-meshheading:10637246-Aged,
pubmed-meshheading:10637246-Aged, 80 and over,
pubmed-meshheading:10637246-Antineoplastic Agents,
pubmed-meshheading:10637246-Cyclophosphamide,
pubmed-meshheading:10637246-Doxorubicin,
pubmed-meshheading:10637246-Female,
pubmed-meshheading:10637246-Granulocyte Colony-Stimulating Factor,
pubmed-meshheading:10637246-Humans,
pubmed-meshheading:10637246-Ligands,
pubmed-meshheading:10637246-Lymphoma,
pubmed-meshheading:10637246-Male,
pubmed-meshheading:10637246-Middle Aged,
pubmed-meshheading:10637246-Neutropenia,
pubmed-meshheading:10637246-Predictive Value of Tests,
pubmed-meshheading:10637246-Receptors, Tumor Necrosis Factor,
pubmed-meshheading:10637246-Risk Assessment,
pubmed-meshheading:10637246-Tumor Necrosis Factor-alpha
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Factors that predict chemotherapy-induced myelosuppression in lymphoma patients: role of the tumor necrosis factor ligand-receptor system.
|
|
pubmed:affiliation |
Service d'Hématologie and Laboratoire d'Immunologie, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
